






Another Name帕纳替尼 、 Ponatinib 、 lclusig 、Ponaxen 、普纳替尼
IndicationsPonatinib for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) and chronic myeloid leukemia (CML).
Reg No.04 L 1090/24
Inspection No.0671-24
WhatsApp: